Search Within

Charlene Claire Kabel

Formats
  1. Journal Article (7)
  2. Meeting Abstract (6)
  3. Review (2)
Groups
  1. Clinical Pharmacy Specialists (15)
  2. Center for Hematologic Malignancies (13)
  3. Department of Medicine (13)
  4. Hematologic Malignancies, Division of (13)
  5. Adult Leukemia (12)
  6. Weinberg Fellows (6)

More Groups

People
  1. Mark Geyer (6)
  2. Anthony Mato (5)
  3. Jae Park (5)
  4. Lindsey Roeker (5)
  5. Martin Tallman (5)
  6. Sarah Stump (5)

More People

Years
  1. 2024 (3)
  2. 2022 (2)
  3. 2021 (1)
  4. 2019 (8)
  5. 2018 (1)
Publications
  1. Blood (5)
  2. Annals of Pharmacotherapy (1)
  3. Blood Advances (1)
  4. Clinical Cancer Research (1)
  5. Clinical Lymphoma, Myeloma and Leukemia (1)
  6. European Journal of Haematology (1)

More Publications

Publishers
  1. American Society of Hematology (6)
  2. Elsevier Ltd (1)
  3. American Association for Cancer Research (1)
  4. American Society of Clinical Oncology (1)
  5. Elsevier Inc. (1)
  6. Ferrata Storti Foundation (1)

More Publishers

Results (15)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Real-world incidence and prevention of tumor lysis syndrome in chronic lymphocytic leukemia treated with venetoclax
    Journal Article

    Valtis, Y. K.; Nemirovsky, D.; Derkach, A.; Sharan, S.; Kabel, C.; Ortiz, R.; Thompson, M. C.; Roeker, L. E.; Geyer, M. B.
    Blood Advances (2024)

    Fulltext@MSK | Save
  • Real world incidence, prevention, and management of tumor lysis syndrome in patients with chronic lymphocytic leukemia treated with venetoclax in the inpatient and outpatient settings
    Meeting Abstract

    Valtis, Y.; Nemirovsky, D.; Derkach, A.; Roeker, L. E.; Sharan, S.; Kabel, C.; Ortiz, R.; Geyer, M. B.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Chimeric antigen receptor (CAR) T-cell therapy use in patients with multiple myeloma and kidney failure on maintenance hemodialysis: A report of 2 cases
    Journal Article

    Pak, W. L. W.; Brumwell, N. A.; Kabel, C. C.; Gutgarts, V.; Jaffer Sathick, I.; Mailankody, S.; Lesokhin, A. M.; Landau, H. J.; Shaikh, A.
    Kidney Medicine (2024)

    Fulltext@MSK | Save
  • Real-world management of targeted therapies in chronic lymphocytic leukemia
    Review

    Weis, T. M.; Gutierrez, J.; Kabel, C. C.; King, A. C.; Daley, R. J.; Stump, S. E.
    Journal of Oncology Pharmacy Practice (2022)

    Fulltext@MSK | Save
  • Treatment outcomes with purine nucleoside analog alone or with rituximab for hairy cell leukemia at first relapse
    Journal Article

    Hu, R.; Wei, W.; Mian, A.; Gonter-Aubin, K.; Kabel, C.; Mato, A.; Stephens, D. M.; Hanlon, A.; Khajavian, S.; Shadman, M.; more...
    European Journal of Haematology (2022)

    Fulltext@MSK | Save
  • Tolerability and toxicity of pegaspargase in adults 40 years and older with acute lymphoblastic leukemia
    Journal Article

    Daley, R. J.; Rajeeve, S.; Kabel, C. C.; Pappacena, J. J.; Stump, S. E.; Lavery, J. A.; Tallman, M. S.; Geyer, M. B.; Park, J. H.
    Leukemia and Lymphoma (2021)

    Fulltext@MSK | Save
  • Inotuzumab ozogamicin is an effective salvage therapy in relapsed/refractory B-cell acute lymphoblastic leukemia with high-risk molecular features, including TP53 loss
    Meeting Abstract

    Yang, X.; King, A. C.; Kabel, C. C.; Forlenza, C. J.; Park, J. H.; Geyer, M. B.
    Blood (2019)

    Fulltext@MSK | Save
  • Toxicities and outcomes of acalabrutinib-treated patients with chronic lymphocytic leukemia: A retrospective analysis of real world patients
    Meeting Abstract

    Yazdy, M. S.; Mato, A. R.; Roeker, L. E.; Jarral, U.; Ujjani, C. S.; Shadman, M.; Skarbnik, A.; Whitaker, K. J.; Deonarine, I.; Kabel, C. C.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Choice of hypomethylating agent (HMA) for initial treatment does not influence outcome or survival for therapy-related myeloid neoplasms (t-MN)
    Meeting Abstract

    Kabel, C. C.; Goldman, D. A.; Buie, L. W.; Klimek, V. M.
    Blood (2019)

    Fulltext@MSK | Save
  • Treatment outcomes with purine nucleoside analog alone or with rituximab for hairy cell leukemia patients at first relapse: A multi-center outcomes analysis
    Meeting Abstract

    Hu, R.; Wei, W.; Gonter-Aubin, K.; Pinilla Ibarz, J.; Kabel, C. C.; Mato, A. R.; Madanat, Y. F.; Khajavian, S.; Shadman, M.; Hanlon, A.; more...
    Blood (2019)

    Fulltext@MSK | Save